← United States · Coverage record
US · SEC FORM 4
CASTLE BIOSCIENCES INC
CSTL · Nasdaq · CIK 0001447362 · Healthcare · Diagnostics & Research
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
138 Form 4 transaction lines observed in the same window
109 sales · 29 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-06-05 · Goldberg Ellen.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,999,726
- Previous report
- 1,899,369
- Avg daily volume
- 419,633
- Days to cover
- 4.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2023-06-05 | Goldberg Ellen | Purchase (P) | Common Stock | 4,800 | USD 14.38 | USD 69,004 | SEC filing ↗ |
| 2022-11-29 | Olson Tiffany | Purchase (P) | Common Stock | 1,162 | USD 21.50 | USD 24,983 | SEC filing ↗ |
| 2022-05-12 | Olson Tiffany | Purchase (P) | Common Stock | 1,320 | USD 18.76 | USD 24,765 | SEC filing ↗ |
Form 4 evidence
236 transaction lines in the latest 365-day window; 2,107 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Juvenal Tobin W | Sale (S) | Common Stock | 3,288 | USD 33.64 | USD 110,608 | SEC filing ↗ |
| 2026-10-05 | MAETZOLD DEREK J | Sale (S) | Common Stock | 14,496 | USD 35.57 | USD 515,565 | SEC filing ↗ |
| 2026-10-05 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 8,165 | USD 2.39 | USD 19,514 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Juvenal Tobin W | Sale (S) | Common Stock | 3,288 | USD 33.64 | USD 110,608 | SEC filing ↗ |
| 2026-10-05 | MAETZOLD DEREK J | Sale (S) | Common Stock | 14,496 | USD 35.57 | USD 515,565 | SEC filing ↗ |
| 2026-10-05 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 8,165 | USD 2.39 | USD 19,514 | SEC filing ↗ |
| 2026-10-01 | Oelschlager Kristen M | Sale (S) | Common Stock | 4,153 | USD 35.95 | USD 149,318 | SEC filing ↗ |
| 2026-10-01 | Oelschlager Kristen M | Option exercise / conversion (M) | Common Stock | 4,153 | USD 3.38 | USD 14,037 | SEC filing ↗ |
| 2026-09-30 | Juvenal Tobin W | Sale (S) | Common Stock | 1,034 | USD 34.20 | USD 35,363 | SEC filing ↗ |
| 2026-09-29 | Juvenal Tobin W | Sale (S) | Common Stock | 5,543 | USD 35.50 | USD 196,765 | SEC filing ↗ |
| 2026-09-21 | MAETZOLD DEREK J | Sale (S) | Common Stock | 14,496 | USD 35.33 | USD 512,144 | SEC filing ↗ |
| 2026-09-21 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 8,580 | USD 2.39 | USD 20,506 | SEC filing ↗ |
| 2026-09-15 | Juvenal Tobin W | Sale (S) | Common Stock | 3,294 | USD 35.14 | USD 115,751 | SEC filing ↗ |
| 2026-09-14 | Juvenal Tobin W | Sale (S) | Common Stock | 3,306 | USD 32.32 | USD 106,850 | SEC filing ↗ |
| 2026-09-11 | MAETZOLD DEREK J | Sale (S) | Common Stock | 14,518 | USD 32.02 | USD 464,870 | SEC filing ↗ |
| 2026-09-11 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 8,584 | USD 2.39 | USD 20,516 | SEC filing ↗ |
| 2026-09-01 | Oelschlager Kristen M | Sale (S) | Common Stock | 4,152 | USD 33.39 | USD 138,643 | SEC filing ↗ |
| 2026-09-01 | Oelschlager Kristen M | Option exercise / conversion (M) | Common Stock | 4,152 | USD 3.38 | USD 14,034 | SEC filing ↗ |
| 2026-08-31 | Juvenal Tobin W | Sale (S) | Common Stock | 1,730 | USD 32.81 | USD 56,761 | SEC filing ↗ |
| 2026-08-28 | MAETZOLD DEREK J | Sale (S) | Common Stock | 17,726 | USD 33.20 | USD 588,448 | SEC filing ↗ |
| 2026-08-28 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 12,428 | USD 2.39 | USD 29,703 | SEC filing ↗ |
| 2026-08-25 | Juvenal Tobin W | Sale (S) | Common Stock | 9,050 | USD 35.04 | USD 317,112 | SEC filing ↗ |
| 2026-08-25 | Oelschlager Kristen M | Sale (S) | Common Stock | 12,384 | USD 34.42 | USD 426,261 | SEC filing ↗ |
| 2026-08-24 | Oelschlager Kristen M | Sale (S) | Common Stock | 12,218 | USD 33.69 | USD 411,624 | SEC filing ↗ |
| 2026-08-17 | Juvenal Tobin W | Sale (S) | Common Stock | 1,730 | USD 29.59 | USD 51,191 | SEC filing ↗ |
| 2026-08-14 | Stokes Frank | Sale (S) | Common Stock | 24,908 | USD 29.77 | USD 741,511 | SEC filing ↗ |
| 2026-08-14 | MAETZOLD DEREK J | Sale (S) | Common Stock | 6,398 | USD 30.02 | USD 192,068 | SEC filing ↗ |
| 2026-08-14 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 1,100 | USD 2.39 | USD 2,629 | SEC filing ↗ |
| 2026-08-05 | MAETZOLD DEREK J | Sale (S) | Common Stock | 3,575 | USD 30.68 | USD 109,681 | SEC filing ↗ |
| 2026-08-05 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 2,546 | USD 2.39 | USD 6,085 | SEC filing ↗ |
| 2026-08-04 | MAETZOLD DEREK J | Sale (S) | Common Stock | 35,441 | USD 31.11 | USD 1,102,657 | SEC filing ↗ |
| 2026-08-04 | MAETZOLD DEREK J | Option exercise / conversion (M) | Common Stock | 20,356 | USD 2.39 | USD 48,651 | SEC filing ↗ |
| 2026-08-03 | Oelschlager Kristen M | Sale (S) | Common Stock | 8,586 | USD 29.77 | USD 255,622 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | CSTL |
| CIK | 0001447362 |
| Sector | Healthcare |
| Industry | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 2,107 transaction lines from 2020-01-28 to 2026-10-12 5 P purchase lines · 1,845 S sale lines · 257 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.